MedTrace Logo

Ketogenic Diet for Patients Receiving Treatment for Metastatic Renal Cell Carcinoma

NCT04316520 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-08-16

No results posted yet for this study

Summary

The purpose of this study is to evaluate the tolerance of one year of ketogenic diet associated with vitamin supplementation in patients treated for a metastatic renal cell carcinoma.

Conditions

  • Metastatic Renal Cancer

Interventions

DIETARY_SUPPLEMENT

Ketogenic diet

Ketogenic diet 2:1

Sponsors & Collaborators

  • Vitaflo International, Ltd

    collaborator INDUSTRY

  • University Hospital, Angers

    lead OTHER_GOV

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-22
Primary Completion
2023-01-06
Completion
2024-03-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04316520 on ClinicalTrials.gov